Kovack Advisors Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 5,202 shares of the healthcare conglomerate’s stock after buying an additional 878 shares during the quarter. Kovack Advisors Inc.’s holdings in UnitedHealth Group were worth $1,824,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. JJJ Advisors Inc. lifted its stake in shares of UnitedHealth Group by 1,820.0% during the 3rd quarter. JJJ Advisors Inc. now owns 96 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 91 shares during the last quarter. Front Row Advisors LLC lifted its stake in shares of UnitedHealth Group by 288.0% during the 3rd quarter. Front Row Advisors LLC now owns 97 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 72 shares during the last quarter. Knuff & Co LLC increased its position in UnitedHealth Group by 666.7% during the third quarter. Knuff & Co LLC now owns 115 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 100 shares during the period. Ossiam increased its position in UnitedHealth Group by 42.5% during the third quarter. Ossiam now owns 124 shares of the healthcare conglomerate’s stock worth $39,000 after acquiring an additional 37 shares during the period. Finally, Old North State Trust LLC bought a new position in UnitedHealth Group during the third quarter worth about $39,000. Institutional investors own 86.39% of the company’s stock.
Shares of NYSE UNH traded up $0.62 during trading on Thursday, hitting $355.66. The stock had a trading volume of 76,719 shares, compared to its average volume of 3,410,015. UnitedHealth Group Incorporated has a 12 month low of $187.72 and a 12 month high of $367.95. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.84. The company has a market capitalization of $337.46 billion, a PE ratio of 20.39, a PEG ratio of 1.53 and a beta of 0.68. The firm has a fifty day moving average of $345.34 and a two-hundred day moving average of $322.90.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm had revenue of $65.12 billion during the quarter, compared to analyst estimates of $63.97 billion. During the same quarter in the prior year, the business posted $3.88 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 16.78 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th were paid a $1.25 dividend. The ex-dividend date was Friday, December 4th. This represents a $5.00 annualized dividend and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 33.09%.
Several equities analysts have commented on the stock. Truist raised their target price on shares of UnitedHealth Group from $400.00 to $420.00 in a report on Tuesday, January 5th. Piper Sandler raised their target price on shares of UnitedHealth Group from $385.00 to $409.00 and gave the company an “overweight” rating in a report on Wednesday, November 11th. BMO Capital Markets raised their price target on shares of UnitedHealth Group from $385.00 to $395.00 and gave the company a “market perform” rating in a research note on Wednesday, December 2nd. They noted that the move was a valuation call. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $360.00 to $375.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Finally, Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $384.00 to $389.00 and gave the stock an “outperform” rating in a research report on Thursday, October 15th. Five analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $383.50.
In related news, EVP Marianne D. Short sold 9,993 shares of the business’s stock in a transaction dated Tuesday, January 5th. The shares were sold at an average price of $348.69, for a total value of $3,484,459.17. Also, EVP Marianne D. Short sold 9,681 shares of the business’s stock in a transaction dated Tuesday, December 29th. The stock was sold at an average price of $348.00, for a total transaction of $3,368,988.00. Following the completion of the transaction, the executive vice president now directly owns 167,202 shares in the company, valued at $58,186,296. The disclosure for this sale can be found here. In the last quarter, insiders sold 130,253 shares of company stock valued at $43,485,730. Company insiders own 0.80% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Story: What moving averages are used to define a golden cross?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.